190 related articles for article (PubMed ID: 22943085)
1. Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series.
Jayawardena J; O'Connor TE; White R; Chai F
ANZ J Surg; 2012 Sep; 82(9):657-8. PubMed ID: 22943085
[No Abstract] [Full Text] [Related]
2. Dosimetric predictors of laryngeal edema.
Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
[TBL] [Abstract][Full Text] [Related]
3. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
[TBL] [Abstract][Full Text] [Related]
4. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.
Caglar HB; Tishler RB; Othus M; Burke E; Li Y; Goguen L; Wirth LJ; Haddad RI; Norris CM; Court LE; Aninno DJ; Posner MR; Allen AM
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1110-8. PubMed ID: 18468812
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer.
Nguyen NP; Ceizyk M; Vos P; Vinh-Hung V; Davis R; Desai A; Abraham D; Krafft SP; Jang S; Watchman CJ; Ewell L; Hamilton R; Smith-Raymond L
Oral Oncol; 2010 Apr; 46(4):283-6. PubMed ID: 20188620
[TBL] [Abstract][Full Text] [Related]
6. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Daly T; Poulsen MG; Denham JW; Peters LJ; Lamb DS; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2003 Aug; 68(2):113-22. PubMed ID: 12972305
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer.
El-Shebiney M; El-Mashad N; El-Mashad W; El-Ebiary AA; Kotkat AE
J Egypt Natl Canc Inst; 2018 Mar; 30(1):33-38. PubMed ID: 29428369
[TBL] [Abstract][Full Text] [Related]
8. Progressive systemic sclerosis (diffuse scleroderma) and radiotherapy.
Cooper SG; Denham JW
Br J Radiol; 1990 Oct; 63(754):804-5. PubMed ID: 2242481
[No Abstract] [Full Text] [Related]
9. [Dysphonia as a symptom of a radiation of the neck].
Reiter R; Pickhard A; Hoffmann TK; Brosch S
Laryngorhinootologie; 2014 Dec; 93(12):859-60. PubMed ID: 25098719
[No Abstract] [Full Text] [Related]
10. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers.
Nguyen TD; Panis X; Froissart D; Legros M; Coninx P; Loirette M
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):23-5. PubMed ID: 3335458
[TBL] [Abstract][Full Text] [Related]
11. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
12. Management of vascular complications of head and neck cancer.
Rimmer J; Giddings CE; Vaz F; Brooks J; Hopper C
J Laryngol Otol; 2012 Feb; 126(2):111-5. PubMed ID: 21888748
[TBL] [Abstract][Full Text] [Related]
13. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971
[TBL] [Abstract][Full Text] [Related]
14. Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial.
Holländer-Mieritz C; Johansen J; Taarnhøj GA; Johansen C; Vogelius IR; Kristensen CA; Pappot H
Acta Oncol; 2020 May; 59(5):603-607. PubMed ID: 32056473
[No Abstract] [Full Text] [Related]
15. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma.
Sanguineti G; Ricchetti F; McNutt T; Wu B; Fiorino C
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):32-8. PubMed ID: 23992739
[TBL] [Abstract][Full Text] [Related]
17. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination.
Rancati T; Fiorino C; Sanguineti G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):915-23. PubMed ID: 19747783
[TBL] [Abstract][Full Text] [Related]
18. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
19. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
[TBL] [Abstract][Full Text] [Related]
20. Development of a standardized method for contouring the larynx and its substructures.
Choi M; Refaat T; Lester MS; Bacchus I; Rademaker AW; Mittal BB
Radiat Oncol; 2014 Dec; 9():285. PubMed ID: 25499048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
